Finance

Beta
Lists
530125:BOM
Samrat Pharmachem Ltd
₹198.75
0.00%
(0.00) 1D
Jun 19, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 530125...
Open
₹197.00
High
₹202.75
Low
₹196.05
Mkt. cap
614.08M
Avg. vol.
3.76K
Volume
3.17K
Dividend
0.50%
Quarterly dividend
₹0.25
Ex-dividend date
Sep 18, 2025
52-wk high
₹389.00
52-wk low
₹190.00
EPS
-₹10.72
Shares outstanding
3.09M
No. of employees
28
Open
₹197.00
High
₹202.75
Low
₹196.05
Mkt. cap
614.08M
Avg. vol.
3.76K
Volume
3.17K
Dividend
0.50%
Quarterly dividend
₹0.25
Ex-dividend date
Sep 18, 2025
52-wk high
₹389.00
52-wk low
₹190.00
EPS
-₹10.72
Shares outstanding
3.09M
No. of employees
28
News stories
From sources across the web
About Samrat Pharmachem Ltd
CEO-
Employees28
Founded1992
Headquarters-
SectorSpeciality chemicals
Websitesamratpharmachem.com
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
756.52M
788.70M
634.26M
717.73M
Cost of goods sold
733.90M
771.46M
617.84M
707.27M
Cost of revenue
733.90M
771.46M
617.84M
707.27M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.08M
5.47M
5.33M
6.88M
Operating expense
23.07M
22.66M
24.84M
24.76M
Total operating expenses
756.97M
794.12M
642.69M
732.03M
Operating income
-456.00K
-5.41M
-8.42M
-14.30M
Other non operating income
6.91M
481.00K
4.01M
-3.07M
EBT including unusual items
2.08M
-7.48M
-5.67M
-18.73M
EBT excluding unusual items
2.08M
-7.48M
-5.67M
-18.73M
Income tax expense
4.37M
-1.61M
-1.08M
1.63M
Effective tax rate
210.15%
21.53%
18.97%
-8.70%
Other operating expenses
16.29M
15.41M
17.65M
16.03M
Net income
-2.29M
-5.87M
-4.60M
-20.36M
Net profit margin
-0.30%
-0.74%
-0.72%
-2.84%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-4.38M
-2.55M
-1.26M
-1.36M
Net interest expenses
-4.38M
-2.55M
-1.26M
-1.36M
Depreciation and amortization charges
1.70M
1.78M
1.86M
1.86M
EBITDA
1.18M
-3.67M
-6.79M
-12.50M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer